Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Peptide Therapeutics Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The peptide therapeutics market has expanded significantly in recent years. Its valuation is set to increase from $49.21 billion in 2025 to $54.62 billion in 2026, indicating a compound annual growth rate (CAGR) of 11.0%. This historical growth can be attributed to the early adoption of peptide drugs, advancements in peptide synthesis techniques, a rising incidence of chronic and rare diseases, progress in pharmacology and biochemistry, and the proliferation of contract research organizations.
The peptide therapeutics market size is projected to experience swift expansion over the coming years. Its value is predicted to reach $83.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.2%. This expansion during the forecast period stems from factors such as the emergence of personalized medicine, augmented funding for peptide-based treatments, the incorporation of AI into drug discovery processes, the broadening of biologics production, and the development of healthcare solutions in nascent markets. Significant trends anticipated during the forecast timeframe encompass the development of targeted peptide drugs, advancements in peptide drug delivery, the emergence of multi-functional peptide therapies, methods for natural peptide extraction and synthesis, and the application of combination therapies utilizing peptides.
Get A Free Sample Report With In-Depth Market Insights:
Peptide Therapeutics Market Growth Drivers: What’s Behind The Acceleration?
The increasing incidence of chronic diseases is expected to propel the growth of the peptide therapeutics market. These are long-lasting health conditions that often cannot be cured, though they are occasionally manageable and treatable. The rise in such diseases stems from increased use of tobacco products, poor nutrition, physical inactivity, excessive alcohol use, and other factors. The application of peptide therapeutics assists in the prevention and treatment of certain chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition is predicted to increase by 99.5%, reaching 142.66 million, by 2050. Therefore, the heightened prevalence of chronic diseases is anticipated to drive the peptide therapeutics market throughout the forecast period.
Peptide Therapeutics Market Breakdown By Product Type And Application
The peptide therapeutics market covered in this report is segmented –
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides
Peptide Therapeutics Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies in the peptide therapeutics market are concentrating on introducing advanced solutions, such as the cell culture process, to gain a competitive advantage. The cell culture process involves growing cells outside their natural environment under controlled conditions, which requires isolating cells of interest from living tissue and subsequently maintaining them. For instance, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, launched cQrex KC. cQrex KC is a next-generation peptide for biopharma applications specifically designed for the cell culture process utilized in the manufacture of biological drugs. It allows cell culture process developers to optimize cystine supply and enhance cell culture productivity. cQrex KC also supports the development of vaccines, viral vectors, and cell therapies.
Peptide Therapeutics Market Company Landscape And Competitive Strategy
Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
View The Full Peptide Therapeutics Market Report:
Peptide Therapeutics Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
